Context Therapeutics Inc (CNTX)

Ticker: CNTX Exchange: NAS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Context Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.2
Lehr Martin A. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
141.88
Quantity 32,890 -26.7%
Value US$4,802,219
2.3
Minai-Azary Jennifer Lynn Chief Financial Officer Officer
Transaction date
Purchase
Price
458.05
Quantity 29,734 -15.3%
Value US$902,376
3.3
Levit Alex C. Chief Legal Officer, Corp. Sec Officer
Transaction date
Purchase
Price
190.36
Quantity 11,028 +47.9%
Value US$801,276
2.2
Lehr Martin A. Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
0.84
Quantity 5,823 +3.8%
Value US$4,900
2.2
Lehr Martin A. Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
0.87
Quantity 5,606 +3.8%
Value US$4,901
2.2
Lehr Martin A. Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
0.97
Quantity 5,040 +3.5%
Value US$4,900
2.2
Lehr Martin A. Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
0.70
Quantity 7,027 +5.2%
Value US$4,901
2.2
Lehr Martin A. Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
0.72
Quantity 6,839 +5.3%
Value US$4,901
2.2
Lehr Martin A. Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
0.74
Quantity 6,783 +5.5%
Value US$4,995
2.2
Lehr Martin A. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.74
Quantity 20,000 +19.5%
Value US$14,796
2.3
Minai-Azary Jennifer Lynn Chief Financial Officer Officer
Transaction date
Purchase
Price
0.74
Quantity 25,000 +166.7%
Value US$18,500
3.3
Levit Alex C. Chief Legal Officer, Corp. Sec Officer
Transaction date
Purchase
Price
0.85
Quantity 6,000 +200.0%
Value US$5,095
2.2
Lehr Martin A. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.85
Quantity 13,000 +14.5%
Value US$24,064
2.3
Minai-Azary Jennifer Lynn Chief Financial Officer Officer
Transaction date
Purchase
Price
1.80
Quantity 15,000 New position
Value US$27,000
0.5
Sahmoud Tarek Chief Medical Officer Officer
Transaction date
Purchase
Price
1.95
Quantity 10,000 New position
Value US$19,500
2.2
Lehr Martin A. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
3.22
Quantity 13,000 +1.6%
Value US$41,850
3.3
Levit Alex C. Chief Legal Officer, Corp. Sec Officer
Transaction date
Purchase
Price
5.00
Quantity 3,000 New position
Value US$15,000
2.2
Lehr Martin A. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
5.00
Quantity 10,000 +11.2%
Value US$50,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2025-06-10 2025-06-09 B Purchase

Chief Executive Officer

Executive Director
32,890 -26.7%
141.88
US$4,802,219
32,890 -26.7% 141.88 US$4,802,219
2025-06-10 2025-06-06 B Purchase

Chief Financial Officer

Officer
29,734 -15.3%
458.05
US$902,376
29,734 -15.3% 458.05 US$902,376
2025-06-10 2025-06-06 B Purchase

Chief Legal Officer, Corp. Sec

Officer
11,028 +47.9%
190.36
US$801,276
11,028 +47.9% 190.36 US$801,276
2023-02-21 2023-02-21 PP Planned purchase

Chief Executive Officer

Executive Director
5,823 +3.8%
0.84
US$4,900
5,823 +3.8% 0.84 US$4,900
2023-02-13 2023-02-13 PP Planned purchase

Chief Executive Officer

Executive Director
5,606 +3.8%
0.87
US$4,901
5,606 +3.8% 0.87 US$4,901
2023-02-06 2023-02-06 PP Planned purchase

Chief Executive Officer

Executive Director
5,040 +3.5%
0.97
US$4,900
5,040 +3.5% 0.97 US$4,900
2023-01-30 2023-01-30 PP Planned purchase

Chief Executive Officer

Executive Director
7,027 +5.2%
0.70
US$4,901
7,027 +5.2% 0.70 US$4,901
2023-01-23 2023-01-23 PP Planned purchase

Chief Executive Officer

Executive Director
6,839 +5.3%
0.72
US$4,901
6,839 +5.3% 0.72 US$4,901
2023-01-18 2023-01-17 PP Planned purchase

Chief Executive Officer

Executive Director
6,783 +5.5%
0.74
US$4,995
6,783 +5.5% 0.74 US$4,995
2022-12-19 2022-12-16 B Purchase

Chief Executive Officer

Executive Director
20,000 +19.5%
0.74
US$14,796
20,000 +19.5% 0.74 US$14,796
2022-12-19 2022-12-16 B Purchase

Chief Financial Officer

Officer
25,000 +166.7%
0.74
US$18,500
25,000 +166.7% 0.74 US$18,500
2022-12-12 2022-12-09 B Purchase

Chief Legal Officer, Corp. Sec

Officer
6,000 +200.0%
0.85
US$5,095
6,000 +200.0% 0.85 US$5,095
2022-08-22 2022-08-19 B Purchase

Chief Executive Officer

Executive Director
13,000 +14.5%
1.85
US$24,064
13,000 +14.5% 1.85 US$24,064
2022-08-17 2022-08-17 B Purchase

Chief Financial Officer

Officer
15,000 New position
1.80
US$27,000
15,000 New position 1.80 US$27,000
2022-08-17 2022-08-16 B Purchase

Chief Medical Officer

Officer
10,000 New position
1.95
US$19,500
10,000 New position 1.95 US$19,500
2021-12-20 2021-12-16 B Purchase

Chief Executive Officer

Executive Director
13,000 +1.6%
3.22
US$41,850
13,000 +1.6% 3.22 US$41,850
2021-10-25 2021-10-22 B Purchase

Chief Legal Officer, Corp. Sec

Officer
3,000 New position
5.00
US$15,000
3,000 New position 5.00 US$15,000
2021-10-25 2021-10-22 B Purchase

Chief Executive Officer

Executive Director
10,000 +11.2%
5.00
US$50,000
10,000 +11.2% 5.00 US$50,000